Gastric candidiasis developing after administration of potassium-competitive acid blocker

A 59-year-old man with type 2 diabetes presented at our hospital because of epigastric pain and nausea. He had a history of gastric ulcers and had undergone Helicobacter pylori eradication therapy 2 years before presenting at  our hospital. EGD showed only ulcer scars in the stomach (A). Esomeprazole (20 mg/day), the proton pump inhibitor taken by the patient for GERD, was changed to a potassium-competitive acid blocker (vonoprazan, 20 mg/day).

Source: Gastrointestinal Endoscopy - June 16, 2019 Category: Gastroenterology Authors: Seiya Kato, Tomofumi Akasaka, Yasuharu Kawamoto, Kiyoshi Mori, Hisashi Ishida Tags: At the focal point Source Type: research